Adverse Event Reporting. In the event that any serious accidents, such as adverse drug reactions, occur during the development of the Licensed Product, both parties shall immediately notify each other of such events together with relevant information that each party may be required to disclose to meet all periodic and annual safety regulatory requirements imposed by the regulatory authorities, and shall discuss the solutions in good faith and take all the necessary measures immediately.
Appears in 6 contracts
Samples: Exclusive Ip License Agreement, Exclusive Ip License Agreement (Aratana Therapeutics, Inc.), Exclusive Ip License Agreement (Aratana Therapeutics, Inc.)